“…In contrast, their analogs such as pyrrolidine, piperidine and nitrogen-containing macrocycles are commonly found in marketed drugs [ 13 ]. Although various factors contribute to the progression of leads that ultimately become clinically approved for use as prescription drugs [ 14 , 15 , 16 , 17 ], the lack of synthetic approaches may limit the drug development process based on privileged structures involving nitrogen-containing medium-sized rings [ 12 , 18 , 19 , 20 ]. Consequently, there is an urgent demand to develop efficient protocols to access libraries of nitrogen-containing medium-sized rings as candidates for drug discovery.…”